APLSApellis Pharmaceuticals Inc
$41.05
$0.015
(0.04%)
EarningsJul 30
Mkt Cap$5.25B
Bright Horizons Family Solutions and Remitly Global Set to Join S&P SmallCap 600
Bright Horizons Family Solutions and Remitly Global Set to Join S&P SmallCap 600 Bright Horizons Family Solutions and Remitly Global Set to Join S&P SmallCap 600 PR Newswire NEW YORK, May 7, 2026 NEW...
PR Newswire
Compared to Estimates, Apellis Pharmaceuticals (APLS) Q1 Earnings: A Look at Key Metrics
The headline numbers for Apellis Pharmaceuticals (APLS) give insight into how the company performed in the quarter ended March 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Zacks
Apellis Pharmaceuticals, Inc. (APLS) Tops Q1 Earnings and Revenue Estimates
Apellis Pharmaceuticals (APLS) delivered earnings and revenue surprises of +139.30% and +33.65%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Zacks
Apellis Pharmaceuticals (NASDAQ:APLS) Reaches New 52-Week High - Here's What Happened
Apellis Pharmaceuticals (NASDAQ:APLS) Sets New 12-Month High - What's Next...
MarketBeat
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Receives Consensus Recommendation of "Hold" from Analysts
Shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Get Free Report) have been assigned an average recommendation of "Hold" from the twenty-three ratings firms that are presently covering the company, MarketBeat Ratings reports. Two analysts have rated the stock with a sell rating, eighteen have...
MarketBeat
Top 3 Health Care Stocks That May Collapse This Month
Stocks AVNS, APLS, and CERS in healthcare sector flashing warning to momentum-sensitive investors. High RSI values & price action indicate overbought conditions. AVNS at 90. APLS at 86. CERS at 86...
Benzinga
Pictet Asset Management Holding SA Has $9.84 Million Stock Holdings in Apellis Pharmaceuticals, Inc. $APLS
Pictet Asset Management Holding SA grew its holdings in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Free Report) by 7.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 390,884 shares of the company's stock after acquiring an...
MarketBeat
UBS Group AG Boosts Stake in Apellis Pharmaceuticals, Inc. $APLS
UBS Group AG raised its holdings in Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Free Report) by 22.1% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,186,222 shares of the company's stock after purchasing an additio...
MarketBeat
Jennison Associates LLC Reduces Holdings in Apellis Pharmaceuticals, Inc. $APLS
Jennison Associates LLC cut its stake in shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS - Free Report) by 65.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,504,299 shares of the company's stock after selling 2,843...
MarketBeat
<
1
2
...
>